(Total Views: 736)
Posted On: 08/07/2020 6:27:29 AM
Post# of 148936
Questions:
1. Did anyone hear about this FDA approval for Dovato (dolutegravir/lamivudine) HIV? Does this affect the chances for Leronlimabs approval?
2. Does this change the timing of the m2m data release?
3. How different are the fdas in the US vs UK?
4. Would this be a “valid all plates” BLA for eu countries brexit notwithstanding?
1. Did anyone hear about this FDA approval for Dovato (dolutegravir/lamivudine) HIV? Does this affect the chances for Leronlimabs approval?
2. Does this change the timing of the m2m data release?
3. How different are the fdas in the US vs UK?
4. Would this be a “valid all plates” BLA for eu countries brexit notwithstanding?
(0)
(0)Scroll down for more posts ▼
